AGITATED SOLUTIONS, INC. — SEC Form D Filing
AGITATED SOLUTIONS, INC. filed an SEC Form D on October 20, 2026, reporting $6.39M raised in Other Health Care.
Form D filing details
- Filing
- SEC Form D
- Filing date
- October 20, 2026
- Amount reported
- $6.39M
- Round stage
- Series A driven by a $6.38M equity round to advance clinical development and commercialization following initial grant funding.
- Industry
- Other Health Care
- Website
- https://agitatedsolutions.com
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Manual preparation of agitated saline contrast for echocardiograms is inconsistent, labor-intensive, and introduces clinical variability into cardiac diagnostic imaging.
Solution
AGITATED SOLUTIONS develops automated fluid agitation and microbubble delivery systems that standardize contrast generation for enhanced diagnostic ultrasound imaging.
Why now
Increasing reliance on point-of-care ultrasound and non-invasive cardiac diagnostics necessitates standardized, operator-independent contrast agent preparation.
Source: SEC EDGAR Form D filing